410 likes | 806 Views
2. Informed Consent - Vulnerable Populations . BackgroundGeneral considerations for vulnerable subjectsConsideration for specific categories of vulnerable subjects Resources. 3. Regulation for Protection of Human Subjects . HHS Regulations: Title 45 CFR part 46Subpart A basic HHS Policy Bas
E N D
1. 1 Informed Consent Processes for Vulnerable Populations Pregnant Women/Fetuses/Neonates,
Prisoners, and Children
Freda E. Yoder
Division of Education & Development
Office for Human Research Protections (OHRP)
Department of Health and Human Services (HHS)
RCF - Richmond, VA
September, 16, 2008
2. 2 Informed Consent - Vulnerable Populations Background
General considerations for vulnerable subjects
Consideration for specific categories of vulnerable subjects
Resources
3. 3 Regulation for Protection of Human Subjects
4. 4 Regulation for Protection of Human Subjects, cont’d
5. 5 Regulations protecting human subjects apply to all non-exempt human subject research conducted or supported by HHS OR covered by an Assurance
6. 6 Basic HHS Regulatory Protections
7. 7 General Informed Consent Considerations
8. 8 No investigator may involve a human being as a subject in research unless the investigator has obtained the legally effective informed consent of the subject or the subject’s legally authorized representative
§46.116
9. 9 Legally Effective - Informed Consent Adults with impaired decision making capacity –generally unable to give legally effective consent
Minors cannot give consent, in most cases
Human fetuses and neonates – cannot give consent
Others
10. 10 When informed consent is required, informed consent must be documented by the use of a written consent form approved by the IRB and signed by the subject or their legally authorized representative – unless waived under §46.117(c)
A copy shall be given to the person signing the form
§46.111(a)(5)
11. 11 Provisions for Alteration or Waiver- Informed Consent and Documentation Provisions for
Alteration or waiver of informed consent: §46.116(c) or (d), §46.408, and §46.101(i)
Waiver of documentation of informed consent: §46.117(c), and 46.101(i)
Note – may not apply to research with some
categories of vulnerable subjects
12. 12 Considerations for
Specific Categories of Vulnerable Subjects
13. 13
14. 14 Subpart B: Pregnant Women,
Human Fetuses and Neonates
15. 15
16. 16
17. 17 Informed Consent – Research with Pregnant Women or Human Fetuses Categories of research
Prospect of direct benefit for woman
Prospect of direct benefit to both woman & fetus
No prospect of direct benefit for woman or fetus
-risk to fetus no greater than minimal
-development of important biomedical knowledge
Consent of pregnant woman in
accordance with subpart A
18. 18 Informed Consent - Research with Pregnant Women or Fetuses, cont’d Categories of research, cont’d
Prospect of direct benefit to fetus only -- Consent of both the pregnant woman and father of fetus in accord with subpart A
Exception if father
unable to consent because of - unavailability, incompetence, or temporary incapacity - OR
pregnancy resulted from rape or incest
Pregnant children - assent and permission per subpart D
19. 19 Informed Consent - Research with Neonates Uncertain viability -
Consent from either parent
Exceptions
if neither parent able to consent …, then IC of either parent’s LAR under subpart A
consent of father not required if pregnancy result of rape or incest
20. 20 Informed Consent - Research with Neonates Nonviable neonate -
Consent from both parents in accordance with subpart A –
Exceptions
only one parent’s consent required if one not able to give consent …
no waiver or alteration of informed consent at §46.116(c) and (d) allowed
no LAR
Viable neonate – under subpart D
21. 21 Subpart B - Other Research Research not otherwise approvable - §46.207
Secretarial Panel process
informed consent - under subpart A and other applicable subparts
Research involving placenta, dead fetus, or fetal material - §46.206
conducted under applicable Federal, State, or local laws and regulations
informed consent - third party considerations
22. 22 Other Considerations Documentation of informed consent in accordance with and to the extent required by §46.117
Secretarial waiver of §46.116 and §46.117 requirements under §46.101(i) for emergency research is not applicable
23. 23
Subpart C: Prisoners
24. 24 General Considerations Among others
Controlled conditions of prison – concerns re:
equitable selection of subjects
voluntariness of consent
Freedom to volunteer for research
25. 25 Informed Consent Considerations, cont’d In general
Informed consent in accord with subpart A, and if applicable, other subparts
Participation must be voluntary
advantages from research not coercive
subject selection without coercion from authorities
no affect on parole – must be so informed, if relevant
26. 26 Informed Consent Considerations, cont’d Waiver or alteration of informed consent
consistent with §46.116(c) or (d) and §46.408 but must be informed that no effect on parole, if relevant
Waiver of documentation under §46.117(c)
Secretarial waiver of §46.116 and §46.117 requirements under §46.101(i) for emergency research is not applicable
Other subpart considerations may apply
27. 27
Subpart D: Children
28. 28 Definition "Children" are persons who have not attained the legal age for consent to treatments or procedures involved in the research, under the applicable law of the jurisdiction in which the research will be conducted - §46.402(a)
29. 29 General Considerations Among others
Not reached full intellectual and emotional capacities
Not able to give legally effective informed consent
Therefore, provisions for permission of parents
and assent of subjects
30. 30 Assent “Assent” means a child’s affirmative agreement to participate in research - §46.402(b)
Required when … children are capable of providing assent. §46.408(a)
Not required if research provides prospect of direct benefits to health or well-being of child & only available in the research context §46.408(b)
May be waived in accordance with §46.116
31. 31 Permission of Parent(s) or Guardian(s) "Permission" means the agreement of parent(s) or guardian to the participation of their child or ward in research. §46.402(c)
32. 32 Parental or Guardian Permission To extent consent is required by §46.116.
Permission of one parent for research
no greater than minimal risk §46.404
greater than minimal risk but prospect of direct benefit - §46.405
Permission both parents for
research greater than minimal risk without direct benefit – but generalizable knowledge about disorder or condition likely - §46.406
Research not otherwise approvable per §46.407. §46.408(b)
33. 33 Waiver of Parental Permission In accordance with §46.116 or
If parental permission is not a reasonable requirement to protect the children, provided that:
an appropriate mechanism for protecting the children is substituted, and
the waiver is not inconsistent with Federal, state or local law
§46.408(c)
34. 34 Wards Appointment of advocate for each child required, in addition to any other individual acting on behalf of the child.
§46.409(a)
35. 35 Documentation of Informed Consent Documentation of parental permission shall be in accord with §46.117
§46.408(d)
The IRB shall determine whether and how assent must be documented
§46.408(e)
36. 36 Other Considerations Timing
Child reaching legal age of consent
Passive consent - not recognized by the regulations at 45 CFR part 46
37. 37 Summary- Vulnerable Populations HHS regulations provide additional protections for research with
Pregnant women, human fetuses and neonates
Prisoners
Children
Special “informed consent” provisions for protecting vulnerable subjects
IRB will ensure that protections are adequate
38. 38
Resources
39. 39 Frequently Asked Questions Informed Consent
http://www.hhs.gov/ohrp/informconsfaq.html
Prisoners
http://www.hhs.gov/ohrp/prisonerfaq.html
Research with Children
http://www.hhs.gov/ohrp/researchfaq.html
Others
http://www.hhs.gov/ohrp/faq.html
40. 40 Other Guidance Informed consent http://www.hhs.gov/ohrp/policy/index.html#informed
Research with Prisoners
http://www.hhs.gov/ohrp/humansubjects/guidance/prisoner.htm
Other Guidance by Topic http://www.hhs.gov/ohrp/policy/index.html#topics
NIH guidance re: research with questionable capacity to consent
http://www.grants.nih.gov/grants/policy/questionablecapacity.htm?Display=Text
41. 41 How to Contact OHRP OHRP Web page: http://www.hhs.gov/ohrp
Join Listserv: http://www.hhs.gov/ohrp/news/index.html
Contact OHRP:
Phone: (240)453-6900, (866) 447-4777
E-mail: ohrp@hhs.gov